Spending years being told that bloating and fatigue were 'just stress' or 'just hormones' — only to finally test positive for a condition that had probably been brewing for a decade — is a story that comes up again and again in this community. The overlap between perimenopause symptoms and celiac disease is so significant that it's genuinely easy for both patients and clinicians to miss. If your gut has changed in midlife and nobody has mentioned celiac testing yet, it's worth asking directly.
Learn more about Rose →The epithelial cells lining the small intestine — exactly the tissue damaged by celiac disease — express estrogen receptors alpha and beta. Estrogen actively supports intestinal barrier integrity, tight junction protein expression, and mucosal healing. As estrogen declines in perimenopause, this protective influence weakens, lowering the threshold at which immune-mediated damage to the gut wall can take hold or progress.
Perimenopause is associated with measurable increases in intestinal permeability — colloquially called 'leaky gut' — partly because estrogen helps regulate the proteins that seal gaps between intestinal cells. In individuals with a genetic predisposition to celiac disease (HLA-DQ2 or HLA-DQ8), increased permeability allows more gluten peptides to cross the gut lining and trigger an immune response. This mechanism may explain why celiac disease sometimes presents clinically for the first time in the fourth or fifth decade of life.
Celiac disease is an autoimmune condition, and autoimmune disorders broadly are more likely to emerge or accelerate around the time of menopause — a pattern seen in rheumatoid arthritis, Hashimoto's thyroiditis, and lupus as well. Estrogen has complex immunomodulatory effects, and its withdrawal alters the balance between regulatory and inflammatory immune responses in ways that can tip a latent autoimmune process into a symptomatic one. Women are already three times more likely than men to develop celiac disease, and hormonal transition appears to be a significant triggering window.
Fatigue, brain fog, joint pain, mood changes, bloating, and disrupted sleep appear on the symptom list for both perimenopause and untreated celiac disease, making it clinically easy to attribute everything to hormones and miss the underlying gut pathology. Studies suggest that undiagnosed celiac disease takes an average of six to ten years to diagnose in adults, and the midlife hormonal transition likely contributes to that delay in women. Recognising which symptoms aren't improving with typical perimenopause strategies is one practical way to prompt further investigation.
Accelerated bone loss is a well-documented consequence of declining estrogen in perimenopause, but it is also one of the most common presentations of undiagnosed celiac disease in adults — caused by malabsorption of calcium and vitamin D through a damaged small intestine. When a midlife woman's DEXA scan shows osteoporosis or significant osteopenia that seems disproportionate to her age or hormonal status, celiac disease should be part of the differential. Missing this connection means treating a symptom while the underlying gut damage continues.
The proximal small intestine — the section most severely damaged in celiac disease — is the primary site of iron absorption, so ongoing iron deficiency despite supplementation is a classic red flag for undiagnosed celiac. In perimenopause, irregular or heavy bleeding can mask this pattern by providing a plausible alternative explanation for low iron. Clinicians and patients who attribute persistent anemia entirely to menstrual irregularity may inadvertently delay a celiac diagnosis by years.
Estrogen influences the composition and diversity of the gut microbiome, and perimenopausal decline is associated with reduced microbial diversity and overgrowth of pro-inflammatory bacterial species. People with active celiac disease show a strikingly similar dysbiotic pattern, including reduced Lactobacillus populations and elevated Bacteroides and Prevotella species. When both processes converge simultaneously, the resulting gut environment may accelerate immune activation and lower the threshold for gluten-triggered inflammation.
Not all gluten-related gut distress in midlife involves the autoimmune mechanism of celiac disease — non-celiac gluten sensitivity (NCGS) is a distinct condition characterised by gut and systemic symptoms that resolve on a gluten-free diet without the intestinal damage or antibodies seen in celiac. The same hormonal shifts that destabilise gut immunity may also lower the threshold for NCGS symptoms to become noticeable or disabling. Because NCGS has no reliable biomarker, it's important to rule out celiac disease formally before experimenting with a gluten-free diet.
This point is critical and frequently mishandled: celiac disease serology (tTG-IgA antibodies) and intestinal biopsy require active gluten consumption to return accurate results — going gluten-free first renders the tests unreliable and can permanently obscure a diagnosis. Any midlife woman with new or worsening gut symptoms, unexplained bone loss, persistent fatigue, or iron deficiency should ask for celiac testing while still eating gluten, before making dietary changes. A confirmed diagnosis matters because celiac disease has lifelong health implications that go well beyond dietary discomfort.
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.